Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1998 Aug;89(8):797–805. doi: 10.1111/j.1349-7006.1998.tb00631.x

Human T‐Lymphotropic Virus Type‐I Infection, Antibody Titers and Cause‐specific Mortality among Atomic‐bomb Survivors

Kokichi Arisawa 1,3,✉, Midori Soda 1, Masazumi Akahoshi 2, Tatsuki Matsuo 4, Eiji Nakashima 6, Masao Tomonaga 5, Hiroshi Saito 3
PMCID: PMC5921919  PMID: 9765614

Abstract

There have been few longitudinal studies on the long‐term health effects of human T‐lymphotropic virus type‐I (HTLV‐I) infection. The authors performed a cohort study of HTLV‐I infection and cause‐specific mortality in 3,090 atomic‐bomb survivors in Nagasaki, Japan, who were followed from 1985–1987 to 1995. The prevalence of HTLV‐I seropositivity in men and women was 99/1,196 (8.3%) and 171/1,894 (9.0%), respectively. During a median follow‐up of 8.9 years, 448 deaths occurred. There was one nonfatal case of adult T‐cell leukemia/lymphoma (incidence rate=0.46 cases/1,000 person‐years; 95% confidence interval [CI] 0.01–2.6). After adjustment for sex, age and other potential confounders, significantly increased risk among HTLV‐I carriers was observed for deaths from all causes (rate ratio [RR]=1.41), all cancers (RR=1.64), liver cancer (RR=3.04), and heart diseases (RR=2.22). The association of anti‐HTLV‐I seropositivity with mortality from all non‐neoplastic diseases (RR=1.40) and chronic liver diseases (RR=5.03) was of borderline significance. Possible confounding by blood transfusions and hepatitis C/B (HCV/HBV) viral infections could not be precluded in this study. However, even after liver cancer and chronic liver diseases were excluded, mortality rate was still increased among HTLV‐I carriers (RR=1.32, 95% CI 0.99–1.78), especially among those with high antibody titers (RR=1.56, 95% CI 0.99–2.46, P for trend=0.04). These findings may support the idea that HTLV‐I infection exerts adverse effects on mortality from causes other than adult T‐cell leukemia/lymphoma. Further studies on confounding by HCV/HBV infections and the interaction between HCV/HBV and HTLV‐I may be required to analyze the increased mortality from liver cancer and chronic liver diseases.

Keywords: key words, Cohort study, HTLV‐I antibody, Liver neoplasms, Lymphoma, Mortality

Full Text

The Full Text of this article is available as a PDF (84.0 KB).

REFERENCES

  • 1. ) Poiesz , B. J. , Ruscetti , F. W. , Gazder , A. F. , Bunn , P. A. , Minna , J. D. and Gallo , R. C.Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous lymphoma . Proc. Natl. Acad. Sci. USA , 77 , 7415 – 7419 ( 1980. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. ) Hinuma , Y. , Nagata , K. , Hanaoka , M. , Nakai , M. , Matsumoto , T. , Kinoshita , K. , Shirakawa , S. and Miyoshi , I.Adult T‐cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera . Proc. Natl. Acad. Sci. USA , 78 , 6476 – 6480 ( 1981. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. ) Gessain , A. , Barin , F. , Vernant , J. C. , Gout , O. , Maurs , L. , Calender , A. and de Thé , G.Antibodies to human T‐lymphotropic virus type‐I in patients with tropical spastic paraparesis . Lancet , ii , 407 – 410 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Osame , M. , Usuku , K. , Izumo , S. , Ijiri , N. , Amitani , H. , Igata , A. , Matsumoto , M. and Tara , M.HTLV‐I‐associated myelopathy, a new clinical entity . Lancet , i , 1031 – 1032 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Nishioka , K. , Maruyama , I. , Sato , K. , Kitajima , I. , Nakajima , Y. and Osame , M.Chronic inflammatory arthropathy associated with HTLV‐I . Lancet , i , 441 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Vernant , J.‐C. , Buisson , G. , Magdeleine , J. , Thore , J. D. , Jouannelle , A. , Neisson‐Vernant , C. and Monplaisir , N.T‐Lymphocyte alveolitis, tropical spastic paraparesis, and Sjögren's syndrome . Lancet , i , 177 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Terada , K. , Katamine , S. , Eguchi , K. , Moriuchi , R. , Kita , M. , Shimada , H. , Yamashita , I. , Iwata , K. , Tsuji , Y. , Nagataki , S. and Miyamoto , T.Prevalence of serum and salivary antibodies to HTLV‐1 in Sjögren's syndrome . Lancet , 344 , 1116 – 1119 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Yamaguchi , K.Human T‐lymphotropic virus type I in Japan . Lancet , 343 , 213 – 216 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Yamashita , I. , Katamine , S. , Moriuchi , R. , Nakamura , Y. , Miyamoto , T. , Eguchi , K. and Nagataki , S.Transactivation of the human interleukin‐6 gene by human T‐lymphotropic virus type 1 Tax protein . Blood , 84 , 1573 – 1578 ( 1994. ). [PubMed] [Google Scholar]
  • 10. ) Welles , S. L. , Tachibana , N. , Okayama , A. , Shioiri , S. , Ishihara , S. , Murai , K. and Mueller , N. E.Decreased reactivity to PPD among HTLV‐I carriers in relation to virus and hematologic status . Int. J. Cancer , 56 , 337 – 340 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Kozuru , M. , Uike , N. , Muta , K. , Goto , T. , Suehiro , Y. and Nagano , M.High occurrence of primary malignant neoplasms in patients with adult T‐cell leukemia/lymphoma, their siblings, and their mothers . Cancer , 78 , 1119 – 1124 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Iwata , K. , Ito , S. , Saito , H. , Ito , M. , Nagatomo , M. , Yamasaki , T. , Yoshida , S. , Suto , H. and Tajima , K.Mortality among inhabitants of an HTLV‐I endemic area in Japan . Jpn. J. Cancer Res. , 85 , 231 – 237 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. ) Ishihara , S. , Okayama , A. , Stuver , S. , Horinouchi , H. , Shioiri , S. , Murai , K. , Kubota , T. , Yamashita , R. , Tachibana , N. , Tsubouchi , H. and Mueller , N.Association of HTLV‐I antibody profile of asymptomatic carriers with proviral DNA levels of peripheral blood mononuclear cells . J. Acquir. Immune Defic. Syndr. , 7 , 199 – 203 ( 1994. ). [PubMed] [Google Scholar]
  • 14. ) Morand‐Joubert , L. , Mariotti , M. , Reed , D. , Petit , J.‐C. and Lefrere , J.‐J.Correlation between viral load and serum anti p19 antibody concentration in symptomless human T‐lymphotropic virus type‐I (HTLV‐I)‐infected individuals . Int. J. Cancer , 60 , 156 – 159 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Matsuo , T. , Nakashima , E. , Carter , R. L. , Neriishi , K. , Mabuchi , K. , Akiyama , M. , Shimaoka , K. , Kinoshita , K. , Tomonaga , M. and Ichimaru , M.Anti‐human T‐lymphotropic virus type‐I antibodies in atomic‐bomb survivors . J. Radiat. Res. , 36 , 8 – 16 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Atomic Bomb Casualty Commission . Research plan for joint ABCC‐NIH Adult Health Study in Hiroshima and Nagasaki . Hiroshima and Nagasaki, Japan: ABCC Technical Report 11–62 ( 1962. ).
  • 17. ) IARC, WHO. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans . Vol. 67 , “Human Immunodeficiency Viruses and Human T‐cell Lymphotropic Viruses” ( 1996. ). IARC; , Lyon , France . [PMC free article] [PubMed] [Google Scholar]
  • 18. ) Maeda , Y. , Imai , J. , Kiyokawa , H. , Kanamura , M. and Hino , S.Performance certification of gelatin particle agglutination assay for anti‐HTLV‐1 antibody: inconclusive positive results . Jpn. J. Cancer Res. , 80 , 915 – 919 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. ) Okochi , K. , Sato , H. and Hinuma , Y.A retrospective study on transmission of adult T‐cell leukemia virus by blood transfusion: seroconversion in recipients . Vox Sang. , 46 , 245 – 253 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Kinoshita , T. , Imamura , J. , Nagai , H. , Ito , M. , Ito , S. , Ikeda , S. , Nagatomo , M. , Tajima , K. and Shimotohno , K.Absence of HTLV‐I infection among seronegative subjects in an endemic area of Japan . Int. J. Cancer , 54 , 16 – 19 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Pierce , D. A. , Shimizu , Y. , Preston , D. L. , Vaeth , M. and Mabuchi , K.Studies of the mortality of atomic bomb survivors. Report 12, Part 1. Cancer: 1950–1990 . Radiat. Res. , 146 , 1 – 27 ( 1996. ). [PubMed] [Google Scholar]
  • 22. ) Collett , D.“Modelling Survival Data in Medical Research” ( 1994. ). Chapman and Hall; , London , UK . [Google Scholar]
  • 23. ) SAS Institute, Inc. SAS/STAT software: Changes and enhancements through Release 6.12 . SAS Institute, Inc. , Cary , NC ( 1997. ). [Google Scholar]
  • 24. ) Maeda , Y. , Furukawa , M. , Takehara , Y. , Yoshimura , K. , Miyamoto , K. , Matsuura , T. , Morishima , Y. , Tajima , K. , Okochi , K. and Hinuma , Y.Prevalence of possible adult T‐cell leukemia virus‐carriers among volunteer blood donors in Japan: a nation‐wide study . Int. J. Cancer , 33 , 717 – 720 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Tajima , K. , Kamura , S. , Ito , S. , Ito , M. , Nagatomo , M. , Kinoshita , K. and Ikeda , S.Epidemiological features of HTLV‐I carriers and incidence of ATL in an ATL‐endemic island: a report of the community‐based cooperative study in Tsushima, Japan . Int. J. Cancer , 40 , 741 – 746 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Tendler , C. L. , Greenberg , S. J. , Blattner , W. A. , Manns , A. , Murphy , E. , Fleisher , T. , Hanchard , B. , Morgan , O. , Burton , J. D. , Nelson , D. L. and Waldman , T. A.Transactivation of interleukin 2 and its receptor induces immune activation in human T‐cell lymphotropic virus type I‐associated myelopathy: pathogenic implications and a rationale for immunotherapy . Proc. Natl. Acad. Sci. USA , 87 , 5218 – 5222 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. ) Wilson , D. E. , Birchfield , G. R. , Hejazi , J. S. , Ward , J. H. and Samlowski , W. E.Hypocholesterolemia in patients treated with recombinant interleukin‐2: appearance of remnant‐like lipoproteins . J. Clin. Oncol. , 7 , 1573 – 1577 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Ho , G. Y. F. , Nelson , K. , Nomura , A. M. Y. , Polk , B. F. and Blattner , W. A.Markers of health status in an HTLV‐I positive cohort . Am. J. Epidemiol. , 136 , 1349 – 1357 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Murphy , E. L. , Wilks , R. , Morgan , O. S. , Hanchard , B. , Cranston , B. , Figueroa , J. P. , Gibbs , W. N. , Murphy , J. and Blattner , W. A.Health effects of human T‐lymphotropic virus type I (HTLV‐I) in a Jamaican cohort . Int. J. Epidemiol. , 25 , 1090 – 1097 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) IARC, WHO. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans . Vol. 59 , “Hepatitis Virus” ( 1994. ). IARC; , Lyon , France . [Google Scholar]
  • 31. ) Kamihira , S. , Yamada , Y. , Sohda , H. , Atogami , S. , Tomonaga , M. , Egawa , S. , Fujii , M. and Chifu , K.Human T‐lymphotropic virus type‐I influence on hepatotropic virus infections and the subsequent development of hepatocellular carcinoma . Cancer Detect. Prev. , 18 , 329 – 334 ( 1994. ). [PubMed] [Google Scholar]
  • 32. ) Okayama , A. , Maruyama , T. , Tachibana , N. , Hayashi , K. , Kitamura , T. , Mueller , N. and Tsubouchi , H.Increased prevalence of HTLV‐I infection in patients with hepatocellular carcinoma associated with hepatitis C virus . Jpn. J. Cancer Res. , 86 , 1 – 4 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. ) Kato , N. , Nakazawa , T. , Mizutani , T. and Shimotohno , K.Susceptibility of human T‐lymphotropic virus type‐I infected cell line MT‐2 to hepatitis C virus infection . Biochem. Biophys. Res. Commun. , 206 , 863 – 869 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 34. ) Stuver , S. O. , Tachibana , N. , Okayama , A. and Mueller , N. E.Evaluation of morbidity among human T lymphotropic virus type I carriers in Miyazaki, Japan . J. Infect. Dis. , 173 , 584 – 591 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 35. ) Rothman , K. J.“Modern Epidemiology” ( 1986. ). Little, Brown and Company; , Boston , MA/Toronto , Ontario . [Google Scholar]
  • 36. ) Ron , E. , Carter , R. , Jablon , S. and Mabuchi , K.Agreement between death certificate and autopsy diagnoses among atomic bomb survivors . Epidemiology , 5 , 48 – 56 ( 1994. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES